Glutamate receptor agonists up-regulate glutamate transporter GLAST in astrocytes

Neuroreport. 1996 Dec 20;8(1):261-5. doi: 10.1097/00001756-199612200-00052.

Abstract

Long-term treatment of astrocytes in primary culture with L-glutamate (0.1-3 mM) resulted in a dose-dependent increase in D-[3H]aspartate uptake. The effect was abolished by an antagonist of kainate/AMPA receptors, CNQX, and mimicked by kainate, but not by AMPA or tACPD. Both glutamate and kainate caused a dramatic up-regulation (82% and 69%, respectively) of GLAST, a predominant glutamate transporter in cultured astroglia, though the mRNA levels appeared unaffected. Long-term treatment of cultures with dBcAMP stimulated D-[3H]aspartate uptake as well as GLAST expression. Apart from glutamate, none of the agonists used was capable of increasing further the uptake capacity of the dBcAMP-treated astroglia. The glutamate receptor-dependent modulation of glutamate transport in astroglial cultures may represent a novel feedback regulatory mechanism for glutamate uptake in the brain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Transport System X-AG
  • Animals
  • Animals, Newborn
  • Aspartic Acid / metabolism
  • Astrocytes / drug effects
  • Astrocytes / metabolism*
  • Blotting, Western
  • Bucladesine / pharmacology
  • Carrier Proteins / biosynthesis*
  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Excitatory Amino Acid Agonists / pharmacology*
  • Excitatory Amino Acid Antagonists / pharmacology
  • Glycoproteins / biosynthesis*
  • Immunoblotting
  • Mice
  • RNA, Messenger / biosynthesis
  • Receptors, Glutamate / drug effects*
  • Up-Regulation / drug effects*

Substances

  • Amino Acid Transport System X-AG
  • Carrier Proteins
  • Excitatory Amino Acid Agonists
  • Excitatory Amino Acid Antagonists
  • Glycoproteins
  • RNA, Messenger
  • Receptors, Glutamate
  • Aspartic Acid
  • Bucladesine